That makes Tirzepatide particularly useful in research focused on: GLP-1 vs dual agonist comparisons body-weight and appetite outcomes glucose homeostasis and insulin dynamics the transition from single-pathway to multi-pathway incretin modulation Published clinical findings on Tirzepatide Tirzepatide has become one of the most closely followed metabolic peptides because published human studies have reported substantial effects on body weight, glycaemic control and broader cardiometabolic markers
Two-month prescriptions will be issued to these patients
Macronutrient Strategy: Support Growth, Insulin Sensitivity, and Recovery Protein: Aim for 1.21.5g per pound of bodyweight, sourced from lean meats, fish, and high-quality supplements like Whey Protein Isolate Carbohydrates: 1.52.5g per pound, with an emphasis on clean, insulin-sensitive options like Clean Carbs Fats: 0.30.5g per pound from anti-inflammatory sources like avocado, extra virgin olive oil, and omega-3s IGF-1 LR3 improves glucose uptake in muscle tissue, making carbohydrate timing around training and injections critical for glycogen replenishment and growth
Thomas Ruiz, OB/GYN lead at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, not involved in this study, expressed some caution about the findings, but also a measure of hope: Its too soon to extrapolate to humans